Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
About the role The National Institute of Health Research (NIHR) is the nation’s largest funder of health and care research and Leicester is home to the Leicester Diabetes Centre, one of the leading NIHR research centres. We are looking recruit a NIHR Programmes Administrator...
-
About the role This is an exciting opportunity to join the School of Healthcare at the University of Leicester as a Lecturer in Physiotherapy, contributing to a unique dual award programme delivered
-
of relevant IT software. You will be fluent in English, sufficient to undertake research and administrative activities utilising English Language materials and to communicate effectively. Also, you will have
-
development of the English language programme. Additionally, as this is a collaborative provision delivered offshore, you should be able to adapt to unpredictable challenges both inside and outside
-
an interdisciplinary project to provide a more integrated picture of life processes in the context of health & disease. This program provides exceptional research, training, and career opportunities, including a 3-month
-
programme delivered in partnership with Chongqing Medical University (CQMU), China. This unique opportunity involves teaching on both the BSc Psychology (University of Leicester) and BSc Psychiatry (CQMU
-
About the role The School of Healthcare are looking for a Lecturer in response to the increasing demand for our pharmacist prescribing program. The pharmacist independent prescribing program at
-
spacecraft data—including from MAVEN, Mars Express, Tianwen-1, and the upcoming EscaPADE mission—you will contribute significantly to a globally collaborative programme within the Planetary Science Group and
-
About the role The new MPharm program, at the University of Leicester, is located in a School of Healthcare, alongside Schools of Medicine, Biology and Psychology. With extensive local expertise in
-
provide infrastructure and help to deliver key grant milestones for the multicentre phase 2/3 COLO-PREVENT clinical trial, which will recruit patients from the NHS Bowel Screening Programme that have a high